ChromaDex (NASDAQ:CDXC) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of ChromaDex (NASDAQ:CDXC – Free Report) in a research note released on Saturday morning. The brokerage issued a buy rating on the stock. A number of other brokerages have also commented on CDXC. HC Wainwright reissued a “buy” rating and issued a $11.00 price target on shares of ChromaDex in […]

Leave a Reply

Your email address will not be published.

Previous post StockNews.com Begins Coverage on Lexicon Pharmaceuticals (NASDAQ:LXRX)
Next post Harley-Davidson (NYSE:HOG) Price Target Cut to $26.00 by Analysts at Robert W. Baird